Both in Pharmaceuticals
Alkermes vs Amneal Pharmaceuticals
Over the past year ALKS returned +40.5% and AMRX returned +104.7%; their daily moves had a correlation of 0.27.
ALKS +40.5% AMRX +104.7%Growth of $1, one year, split-adjusted
| Metric | ALKS | AMRX |
|---|---|---|
| Price | $40.80 | $20.20 |
| Market cap | $6.84B | $7.04B |
| Today | +1.62% | −1.46% |
| 1 month | −13.9% | +15.2% |
| 6 months | +35.3% | +69.0% |
| Year to date | +45.8% | +60.3% |
| 1 year | +46.3% | +107.2% |
| Revenue growth (YoY) | +27.0% | +9.9% |
| Gross margin | 80.2% | 42.0% |
| Net margin | 0.1% | 7.2% |
| P/E (TTM) | 103.5× | 44.7× |
| Price / sales | 4.1× | 2.3× |
| Net cash | -$846.5M | -$2.54B |
| Dividend yield | — | — |
| Volatility (60d) | 30.5% | 40.0% |
| Short % of float | 9.2% | 6.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).